Feasability and efficacy of a 2-weekly Taxol, Epirubicin and Cisplatin (TEC) regimen in patients with advanced ovarian cancer

J.B Vermorken, R.V.H.P. Huijskes, K. Hoekman, C.W. Burger, E. Muller, D. Eshuis, RHM Verheijen, P. Kenemans, H.M. Pinedo

Research output: Contribution to conferenceAbstractOther research output

Original languageEnglish
Publication statusPublished - 1996
EventAACR - , United Kingdom
Duration: 4 Oct 1996 → …

Conference

ConferenceAACR
Country/TerritoryUnited Kingdom
Period4/10/96 → …

Cite this